how automated healthcare fails, how you'd know, and what to do at each tier — every claim sourced, reviewed continuously
Nova Biomedical's StatStrip Gen 2.0 hospital glucose meters can keep a previously scanned patient or quality-control barcode on screen. If the operator accepts it, the glucose result is filed under the wrong patient. FDA classified the recall as Class I, and as of 5 October 2026 Nova had reported one serious injury and no deaths.
TierThe meters stayed in use with added manual identity checks, or were swapped for alternative meters; wrong output does not change tier, and no loss of automation is documented. How tiers are assigned.
FDA's notice, issued on 20 October 2026 and updated on 30 October to clarify recommended actions, says earlier information can stay on the meter screen when patient ID or quality-control barcodes are scanned. If the operator accepts it, the glucose result is assigned to the wrong patient's record or QC ID. Nova says analytical performance is not affected and that the issue affects all firmware versions of the Gen 2.0 model (models 63685 and 66739). Nova's announcement says earlier generations (1.0, 1.75, 1.86 and 1.87) are not affected. According to FDA, clinicians may act on another patient's result, which can lead to delayed treatment, unnecessary treatment including inappropriate insulin, or no treatment for the intended patient. FDA says critically ill patients and infants are at greater risk. Nova's announcement, posted by FDA on 6 October 2026, says the correction began on 24 July 2026. It says that on 17 July 2026 Nova received one U.S. report of inappropriate insulin administration based on another patient's glucose result, and it also states that no serious adverse events related to the issue have been reported. FDA's notice says that as of 5 October Nova had reported one serious injury and no deaths. FDA dates Nova's first customer letter 31 July, with an update on 5 October. Nova has put new Gen 2.0 shipments on hold and plans a phased software update starting in November 2026. Until then, FDA's notice tells users to enable the 'Validate Patient ID's' setting in NovaNet where ADT data is used, and to set operator logoff to 'Test' mode. Staff should check the patient ID at scanning and again on the result screen, and flag or remove any misassigned result and tell the administrator. Facilities with an alternative meter should stop using the affected meters until they are updated. Clinical Lab Products reported the same defect, injury count and interim measures.[1,2,3]
FDA's notice says that as of 5 October 2026 Nova had reported one serious injury and no deaths. Nova's announcement describes one U.S. report of inappropriate insulin administration based on another patient's result, while also stating that no serious adverse events related to the issue had been reported.
Information only, not advice. FailSystems is an aggregation and synthesis of published sources. It is not consulting, engineering, legal, regulatory or medical advice, and using it creates no professional relationship. Health systems are complex and no approach fits every organisation: anything you adopt is your own decision, at your own risk, and should be checked against the current official sources and by qualified people who know your setting. Full disclaimer.